SEC Form D · filed December 15, 2016
Aridis Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Isaac R. Blech · San Jose, CADirectorRobert R. Ruffolo, Jr · San Jose, CADirectorVu Troung · San Jose, CAExec · DirectorRobert K. Coughlin · San Jose, CADirectorCraig K. Gibbs · San Jose, CADirectorJohn K. Hamilton · San Jose, CADirectorPaul-Andre De Lame · San Jose, CAExecFred Kurland · San Jose, CAExecEric Patzer · San Jose, CAExec · DirectorThomas Hartland-Mackie · Dallas, TXDirectorMichael E. Keller · Greenwich, CTExecNicholas Naclerio · San Francisco, CAExecNasiba Hartland-Mackie · Dallas, TXDirectorKe Cheng · Raleigh, NCExec · DirectorBradley Messmer · San Diego, CADirectorWilliam Rutledge · Pacific Palisades, CADirectorTim M. Flynn · Riverside, CAExec · DirectorMamadou S. Diallo · Pasadena, CADirectorNeil Senturia · San Diego, CADirectorRichard D. Carlson · Gainesville, FLExec · DirectorWilliam D. Pruitt · CORAL GABLES, FLDirectorBrett S. Harrison · Denver, COExecAdam B. Antoniades · San Diego, CAExecBernie Breton · Denver, CODirectorElizabeth C. Williamson · Chicago, ILDirectorCassandra A. Knight · Oshkosh, WIDirectorSusan W. Stevens · PORTLAND, ORExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗